3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
2
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Rectal Neoplasms
1
Polyps
1
Neoplastic Syndromes, Hereditary
1
Neoplasms, Germ Cell and Embryonal
1
Medulloblastoma
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Hepatoblastoma
1
Genetic Diseases, Inborn
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Barrett Esophagus
1
Adenomatous Polyps
1
Adenomatous Polyposis Coli
1
Adenoma
1
Interventions
Gemcitabine
5
130-nm albumin-bound paclitaxel
5
Albumin-Bound Paclitaxel
4
napabucasin
3
Ocoxin
3
Irinotecan
3
Fluorouracil
3
Paclitaxel
2
Oxaliplatin
2
Nivolumab
2
Leucovorin
2
Cyclophosphamide
2
Capecitabine
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
trametinib
1
pralsetinib
1
pembrolizumab
1
ozanimod
1
halofantrine
1
guadecitabine
1
ficlatuzumab
1
Ursodeoxycholic Acid
1
Sorafenib
1
Radiotherapy
1
Pemetrexed
1
Oviposition
1
Nadroparin
1
Lenalidomide
1
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Digestive System Diseases
×
Ursodeoxycholic Acid
×
Clear all
NCT00808743
2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3
Completed
37 enrolled